OncoCyte (OCX) Misses Q4 EPS by 193c

OncoCyte (NASDAQ: OCX) reported Q4 EPS of ($1.93). Revenue for the quarter came in at $1.49 million.

For earnings history and earnings-related data on OncoCyte (OCX) click here.

You May Also Be Interested In

• JPMorgan Starts TIME dotCom Berhad (TDC:MK) at Overweight
• GameStop 'remains focused on advancing' proposed eBay deal, offers adjusted EBITDA guidance - Filing
• Magnolia Said In Lead To Acquire Wildfire For Over $4 Billion - Bloomberg